{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:24:05Z","timestamp":1791829445768,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Medical Scientific Research project","award":["No.2023ZDXM011"],"award-info":[{"award-number":["No.2023ZDXM011"]}]},{"name":"Chongqing Medical Scientific Research project","award":["No.2023ZDXM011"],"award-info":[{"award-number":["No.2023ZDXM011"]}]},{"name":"Chongqing Medical Scientific Research project","award":["No.2023ZDXM011"],"award-info":[{"award-number":["No.2023ZDXM011"]}]},{"name":"Chongqing Medical Scientific Research project","award":["No.2023ZDXM011"],"award-info":[{"award-number":["No.2023ZDXM011"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["No. W0188"],"award-info":[{"award-number":["No. W0188"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["No. W0188"],"award-info":[{"award-number":["No. W0188"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["No. W0188"],"award-info":[{"award-number":["No. W0188"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["No. W0188"],"award-info":[{"award-number":["No. W0188"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81701384"],"award-info":[{"award-number":["No. 81701384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Municipal Education Commission","award":["No.KJQN202100462"],"award-info":[{"award-number":["No.KJQN202100462"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76829-5","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:02:20Z","timestamp":1729562540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhulu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diansa","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"76829_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"76829_CR2","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon, A. R. et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur. Heart J. 43, 4229\u20134361 (2022).","journal-title":"Eur. Heart J."},{"key":"76829_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72, 409\u2013436 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"76829_CR4","doi-asserted-by":"publisher","first-page":"S315","DOI":"10.1016\/j.cjca.2023.09.024","volume":"39","author":"E Pituskin","year":"2023","unstructured":"Pituskin, E. et al. Cardio-oncology and cancer rehabilitation: is an integrated approach possible? Can. J. Cardiol. 39, S315\u2013S322 (2023).","journal-title":"Can. J. Cardiol."},{"key":"76829_CR5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"76829_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino, M. S., Larkin, J. & Long, G. V. Immune checkpoint inhibitors in melanoma. Lancet 398, 1002\u20131014 (2021).","journal-title":"Lancet"},{"key":"76829_CR7","first-page":"1","volume":"22","author":"S Li","year":"2021","unstructured":"Li, S. et al. Programmed death-ligand 2 deficiency exacerbates experimental autoimmune myocarditis in mice. Int. J. Mol. Sci. 22, 1 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"76829_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI145186","volume":"131","author":"J Moslehi","year":"2021","unstructured":"Moslehi, J. et al. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. J. Clin. Investig. 131, 1 (2021).","journal-title":"J. Clin. Investig."},{"key":"76829_CR9","first-page":"6074","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study. Am. J. Cancer Res. 11, 6074\u20136085 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"76829_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-019-0535-y","volume":"7","author":"M Awadalla","year":"2019","unstructured":"Awadalla, M. et al. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. J. Immunother. Cancer 7, 53 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"76829_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1634\/theoncologist.2018-0157","volume":"23","author":"TG Neilan","year":"2018","unstructured":"Neilan, T. G. et al. Myocarditis associated with immune checkpoint inhibitors: an expert consensus on data gaps and a call to action. Oncologist 23, 874\u2013878 (2018).","journal-title":"Oncologist"},{"key":"76829_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-001719","volume":"9","author":"TA Sussman","year":"2021","unstructured":"Sussman, T. A. et al. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival. J. Immunother. Cancer 9, 1 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"76829_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/cvr\/cvz026","volume":"115","author":"JR Hu","year":"2019","unstructured":"Hu, J. R. et al. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc. Res. 115, 854\u2013868 (2019).","journal-title":"Cardiovasc. Res."},{"key":"76829_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann, J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat. Rev. Cardiol. 17, 474\u2013502 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"76829_CR15","doi-asserted-by":"publisher","first-page":"e13400","DOI":"10.1111\/eci.13400","volume":"51","author":"S Petricciuolo","year":"2021","unstructured":"Petricciuolo, S. et al. Pre-treatment high-sensitivity troponin T for the short-term prediction of cardiac outcomes in patients on immune checkpoint inhibitors. Eur. J. Clin. Investig. 51, e13400 (2021).","journal-title":"Eur. J. Clin. Investig."},{"key":"76829_CR16","doi-asserted-by":"publisher","first-page":"753313","DOI":"10.3389\/fcvm.2021.753313","volume":"8","author":"H Xiao","year":"2021","unstructured":"Xiao, H. et al. Advances in biomarkers for detecting early cancer treatment-related cardiac dysfunction. Front. Cardiovasc. Med. 8, 753313 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"76829_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaccao.2022.12.007","volume":"5","author":"R Velusamy","year":"2023","unstructured":"Velusamy, R. et al. Screening for coronary artery disease in cancer survivors. JACC CardioOncol. 5, 22\u201338 (2023).","journal-title":"JACC CardioOncol."},{"key":"76829_CR18","doi-asserted-by":"publisher","first-page":"879900","DOI":"10.3389\/fimmu.2022.879900","volume":"13","author":"X Xie","year":"2022","unstructured":"Xie, X. et al. Multi-organ immune-related adverse event is a risk factor of immune checkpoint inhibitor-associated myocarditis in cancer patients: a multi-center study. Front. Immunol. 13, 879900 (2022).","journal-title":"Front. Immunol."},{"key":"76829_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.123.062405","volume":"148","author":"LH Lehmann","year":"2023","unstructured":"Lehmann, L. H. et al. Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis. Circulation 148, 473\u2013486 (2023).","journal-title":"Circulation"},{"key":"76829_CR20","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599\u20133726 (2021).","journal-title":"Eur. Heart J."},{"key":"76829_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1253\/circj.CJ-22-0696","volume":"87","author":"T Nagai","year":"2023","unstructured":"Nagai, T. et al. JCS 2023 guideline on the diagnosis and treatment of myocarditis. Circ. J. 87, 674\u2013754 (2023).","journal-title":"Circ. J."},{"key":"76829_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jchf.2020.10.013","volume":"9","author":"A Pandey","year":"2021","unstructured":"Pandey, A. et al. Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes. JACC Heart Fail. 9, 215\u2013223 (2021).","journal-title":"JACC Heart Fail."},{"key":"76829_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.117.027272","volume":"135","author":"JA de Lemos","year":"2017","unstructured":"de Lemos, J. A. et al. Multimodality strategy for cardiovascular risk assessment: performance in 2 population-based cohorts. Circulation 135, 2119\u20132132 (2017).","journal-title":"Circulation"},{"key":"76829_CR24","doi-asserted-by":"publisher","first-page":"1052699","DOI":"10.3389\/fcvm.2023.1052699","volume":"10","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: a single-center prospective clinical study. Front. Cardiovasc. Med. 10, 1052699 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"76829_CR25","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.21.01808","volume":"40","author":"D Laenens","year":"2022","unstructured":"Laenens, D. et al. Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors. J. Clin. Oncol. 40, 3430\u20133438 (2022).","journal-title":"J. Clin. Oncol."},{"key":"76829_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph16040625","volume":"16","author":"D Delombaerde","year":"2023","unstructured":"Delombaerde, D. et al. Extensive cardiovascular characterization and follow-up of patients receiving immune checkpoint inhibitors: a prospective multicenter study. Pharmaceuticals (Basel) 16, 1 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"key":"76829_CR27","doi-asserted-by":"publisher","first-page":"1112276","DOI":"10.3389\/fonc.2023.1112276","volume":"13","author":"J Ros","year":"2023","unstructured":"Ros, J. et al. Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer. Front. Oncol. 13, 1112276 (2023).","journal-title":"Front. Oncol."},{"key":"76829_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.6004\/jnccn.2020.0012","volume":"18","author":"JA Thompson","year":"2020","unstructured":"Thompson, J. A. et al. NCCN guidelines insights: management of immunotherapy-related toxicities, version 1.2020. J. Natl. Compr. Cancer Netw. 18, 230\u2013241 (2020).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"76829_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcct.2016.11.003","volume":"11","author":"HS Hecht","year":"2017","unstructured":"Hecht, H. S. et al. 2016 SCCT\/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and society of thoracic Radiology. J. Cardiovasc. Comput. Tomogr. 11, 74\u201384 (2017).","journal-title":"J. Cardiovasc. Comput. Tomogr"},{"key":"76829_CR30","doi-asserted-by":"publisher","first-page":"739514","DOI":"10.3389\/fimmu.2021.739514","volume":"12","author":"N Yu","year":"2021","unstructured":"Yu, N. et al. Circulating metabolomic signature in generalized pustular psoriasis blunts monocyte hyperinflammation by triggering amino acid response. Front. Immunol. 12, 739514 (2021).","journal-title":"Front. Immunol."},{"key":"76829_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00011-020-01429-8","volume":"70","author":"Y Shen","year":"2021","unstructured":"Shen, Y. et al. Relationship between the dynamic changes of serum 2019-nCoV IgM\/IgG and patient immunity after 6 month hospital discharge. Inflamm. Res. 70, 241\u2013247 (2021).","journal-title":"Inflamm. Res."},{"key":"76829_CR32","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.7150\/thno.16093","volume":"6","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Accurate quantification of disease markers in human serum using iron oxide nanoparticle-linked immunosorbent assay. Theranostics 6, 1353\u20131361 (2016).","journal-title":"Theranostics"},{"key":"76829_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S0033291716001574","volume":"47","author":"JF Hayes","year":"2017","unstructured":"Hayes, J. F. et al. Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study. Psychol. Med. 47, 23\u201333 (2017).","journal-title":"Psychol. Med."},{"key":"76829_CR34","doi-asserted-by":"publisher","first-page":"e000531","DOI":"10.1136\/esmoopen-2019-000531","volume":"4","author":"S Iivanainen","year":"2019","unstructured":"Iivanainen, S. et al. Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors. ESMO Open 4, e000531 (2019).","journal-title":"ESMO Open."},{"key":"76829_CR35","doi-asserted-by":"crossref","unstructured":"Riedl, J. M. et al. C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: a bi-center study. Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12082319"},{"key":"76829_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ekir.2021.01.013","volume":"6","author":"B Isik","year":"2021","unstructured":"Isik, B. et al. Biomarkers, clinical features, and rechallenge for immune checkpoint inhibitor renal immune-related adverse events. Kidney Int. Rep. 6, 1022\u20131031 (2021).","journal-title":"Kidney Int. Rep."},{"key":"76829_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12282-017-0778-8","volume":"24","author":"H Kitayama","year":"2017","unstructured":"Kitayama, H. et al. High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients. Breast Cancer 24, 774\u2013782 (2017).","journal-title":"Breast Cancer"},{"key":"76829_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-020-00930-x","volume":"22","author":"V Bracun","year":"2020","unstructured":"Bracun, V. et al. Cardiac biomarkers in patients with cancer: considerations, clinical implications, and future avenues. Curr. Oncol. Rep. 22, 67 (2020).","journal-title":"Curr. Oncol. Rep."},{"key":"76829_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.breast.2015.10.004","volume":"25","author":"I Palumbo","year":"2016","unstructured":"Palumbo, I. et al. Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: a prospective study. Breast 25, 45\u201350 (2016).","journal-title":"Breast"},{"key":"76829_CR40","doi-asserted-by":"publisher","first-page":"e96736","DOI":"10.1371\/journal.pone.0096736","volume":"9","author":"D Skovgaard","year":"2014","unstructured":"Skovgaard, D., Hasbak, P. & Kjaer, A. BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography. PLoS ONE 9, e96736 (2014).","journal-title":"PLoS ONE"},{"key":"76829_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ejhf.1631","volume":"22","author":"L Michel","year":"2020","unstructured":"Michel, L. et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur. J. Heart Fail. 22, 350\u2013361 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"76829_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","volume":"72","author":"P Greenland","year":"2018","unstructured":"Greenland, P. et al. Coronary calcium score and cardiovascular risk. J. Am. Coll. Cardiol. 72, 434\u2013447 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"76829_CR43","doi-asserted-by":"publisher","first-page":"110040","DOI":"10.1016\/j.ejrad.2021.110040","volume":"145","author":"M Mascalchi","year":"2021","unstructured":"Mascalchi, M. et al. Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: the ITALUNG trial. Eur. J. Radiol. 145, 110040 (2021).","journal-title":"Eur. J. Radiol."},{"key":"76829_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2019.01.056","volume":"289","author":"WJ Phillips","year":"2019","unstructured":"Phillips, W. J. et al. Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events. Int. J. Cardiol. 289, 138\u2013143 (2019).","journal-title":"Int. J. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76829-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:13:26Z","timestamp":1729836806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76829"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76829-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24821"}}